Ionis Pharmaceuticals, Inc. (IONS) Gross margin 2016–2025
Ionis Pharmaceuticals, Inc. (IONS) gross margin by fiscal year — reported gross profit divided by reported revenue.
98.3%FY2025 · since FY2016: 100.0% → 98.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 98.3% | -0.1 pp |
| FY2024 | 98.4% | -0.4 pp |
| FY2023 | 98.8% | +1.2 pp |
| FY2022 | 97.6% | -1.1 pp |
| FY2021 | 98.7% | +0.3 pp |
| FY2020 | 98.4% | -1.2 pp |
| FY2019 | 99.6% | -0.1 pp |
| FY2018 | 99.7% | -0.3 pp |
| FY2017 | 100.0% | +0.0 pp |
| FY2016 | 100.0% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice